Markets.com Logo

CHRRF

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    14.4084$
  • Previous Close
    14.4084$
  • 52 Week Change
    4.39$
  • Day Range
    0.00$
  • 52 Week High/Low
    12.5539$ - 16.9479$
  • Dividend Per Share
    0
  • Market cap
    377 M$
  • EPS
    0.8896
  • Beta
    1.947
  • Volume
    --

About

CHRRF.US represents stock in Chrysos Corporation, an Australian company specializing in mineral analysis technology for the mining industry. The symbol is used to denote its over-the-counter (OTC) trading of shares in the United States. The company's primary technology, PhotonAssay, is a faster and more environmentally friendly alternative to traditional fire assay methods for determining gold and other precious metal concentrations in samples.
USD/CAD Forecast: Oil Weakness Keeps 1.4000 in Focus

USD/CAD Forecast: Oil Weakness Keeps 1.4000 in Focus

Julian Parker|--
Bitcoin and the Fed’s Guidance Shift: Short-Term Risk, Long-Term Narrative

Bitcoin and the Fed’s Guidance Shift: Short-Term Risk, Long-Term Narrative

Julian Parker|--
Silver Price Forecast: XAG/USD Holds Below $70 as Fed Decision Shapes Outlook

Silver Price Forecast: XAG/USD Holds Below $70 as Fed Decision Shapes Outlook

Julian Parker|--
EUR/USD Outlook: Dollar Firms Before Fed Decision as Euro Rally Loses Momentum

EUR/USD Outlook: Dollar Firms Before Fed Decision as Euro Rally Loses Momentum

Julian Parker|--
Why SpaceX's $2 Trillion Listing Is a Watershed for Middle East CFD Traders

Why SpaceX's $2 Trillion Listing Is a Watershed for Middle East CFD Traders

Julian Parker|--
SpaceX IPO Aftermath: High-Conviction CFD Strategies for Middle East Investors

SpaceX IPO Aftermath: High-Conviction CFD Strategies for Middle East Investors

Julian Parker|--
Gulf Capital Fuels the SpaceX IPO: What Sovereign Money Signals for Middle East CFD Traders

Gulf Capital Fuels the SpaceX IPO: What Sovereign Money Signals for Middle East CFD Traders

Julian Parker|--

Factors

[Company Performance]: Strong revenue growth, profitability, and positive clinical trial results for ChromaDex's Niagen product generally boost investor confidence and drive up the stock price.

[Regulatory Environment]: Favorable decisions from regulatory bodies, such as FDA approvals or positive safety assessments of Niagen, tend to increase demand and positively impact the stock's value.

[Market Sentiment]: Overall market conditions, economic outlook, and investor risk appetite influence the demand for CHRRF.US. Positive market sentiment can lead to increased buying pressure.

[Competition]: The emergence of competing products or increased competition in the NAD+ boosting supplement market could negatively impact ChromaDex's market share and stock price.

[Intellectual Property]: The strength and protection of ChromaDex's patents surrounding Niagen are critical. Any challenges to their IP rights could create uncertainty and lower the stock price.

People Also Watch

Latest news

Gold Price Today, June 17, 2026: Gold Holds Near One-Week High as Oil Slump Eases Fed Rate-Hike Fears

Gold Price Today, June 17, 2026: Gold Holds Near One-Week High as Oil Slump Eases Fed Rate-Hike Fears

Julian Parker|--
Brent Crude Falls Below $80 as Goldman Sachs and Morgan Stanley Cut Oil Forecasts

Brent Crude Falls Below $80 as Goldman Sachs and Morgan Stanley Cut Oil Forecasts

Julian Parker|--
SpaceX Stock Rally Extends as Options Debut Fuels Post-IPO Surge

SpaceX Stock Rally Extends as Options Debut Fuels Post-IPO Surge

Julian Parker|--

Latest Education Articles

High-Leverage Forex Brokers: What Traders Need to Know Before Using High Leverage

High-Leverage Forex Brokers: What Traders Need to Know Before Using High Leverage

Julian Parker|--
Forex Trading Tax South Africa: How SARS Treats Forex Profits

Forex Trading Tax South Africa: How SARS Treats Forex Profits

Julian Parker|--
Trading Session Time in South Africa: Best Forex Market Hours in SAST

Trading Session Time in South Africa: Best Forex Market Hours in SAST

Julian Parker|--
Recommended Topics